News on medical imaging technologies and applications.
Androvia LifeSciences has developed a predictive biomarker test that some clinicians are using to determine a man's fertility.
CDx Diagnostics reported that crypt dysplasia, identified and analyzed using its three-dimensional detection and surveillance system, could present a risk for esophageal cancer.
The mobile approach enables stroke patients to be assessed within the three-hour window for stroke treatment.
The firm will use the funds to expand deployment of its digital pathology software and accelerate use of artificial intelligence applications.
The microfluidics- and machine vison-based diagnostic may improve risk stratification of patients and reduce overtreatment, according to the company.
